Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 9,153 shares at $630.84 ($5.7M) on 2020-06-23, disclosed to the SEC on 2020-06-24.
Open-market sale of $5.7M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $626.19 | 8,388 | $5.3M | 91.6% |
| 2 | $624.65 | 40 | $25K | 0.4% |
| 3 | $626.56 | 56 | $35K | 0.6% |
| 4 | $628.64 | 39 | $25K | 0.4% |
| 5 | $630.84 | 82 | $52K | 0.9% |
| 6 | $630.84 | 82 |
| $52K |
| 0.9% |
| 7 | $631.25 | 78 | $49K | 0.9% |
| 8 | $633.56 | 82 | $52K | 0.9% |
| 9 | $633.56 | 82 | $52K | 0.9% |
| 10 | $634.63 | 89 | $56K | 1.0% |
| 11 | $634.63 | 89 | $56K | 1.0% |
| 12 | $635.24 | 46 | $29K | 0.5% |
| Total | $626.66 avg | 9,153 | $5.7M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |